Printer Friendly

BIOMERICA'S ULCER TEST APPROVED IN JAPAN

 BIOMERICA'S ULCER TEST APPROVED IN JAPAN
 NEWPORT BEACH, Calif., Sept. 17 /PRNewswire/ -- Biomerica Inc.


(NASDAQ: BMRA) announced that its blood test for ulcer and other gastric ailments, including stomach cancer (H. pylori), has been approved for sale in Japan. The approval came after a year of intensive clinical studies by one of the largest laboratories in Japan using Biomerica's product.
 Being the first to introduce the ulcer test in Japan through a large Japanese firm, Biomerica anticipates significant revenue generated for the current fiscal year.
 Biomerica is a medical company engaged in the development, manufacturing and marketing of advanced medical diagnostic products including home self-testing.
 -0- 9/17/92
 /CONTACT: Joseph Irani, president of Biomerica, 714-645-2111/
 (BMRA) CO: Biomerica Inc. ST: California IN: MTC SU: PDT


JB-KJ -- LA001 -- 0547 09/17/92 10:31 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 17, 1992
Words:135
Previous Article:THE FIRST TO OFFER PREFERRED STOCK
Next Article:AIR FORCE CHIEF OF STAFF TO REVAMP ENLISTED TRAINING SYSTEM
Topics:


Related Articles
BIOMERICA SIGNS AN AGREEMENT WITH SAV-ON/OSCO FOR DISTRIBUTION OF STOOL BLOOD TEST KIT
BIOMERICA SIGNS HOOK DRUGS FOR DISTRIBUTION OF STOOL BLOOD TEST KIT
BIOMERICA SIGNS McKESSON FOR DISTRIBUTION OF EZ DETECT PRODUCTS
BIOMERICA H. PYLORI TEST SALES SHOULD BENEFIT FROM NIH ANNOUNCEMENT
BIOMERICA LAUNCHES OTC PREGNANCY TEST IN EUROPE
BIOMERICA TO REVERSE SPLIT ITS STOCKAND LOOKS FORWARD TO GOOD PERFORMANCE IN THE 2ND QUARTER
BIOMERICA SIGNS AGREEMENT TO PROVIDE PRODUCT TO BIORAD
BIOMERICA INTRODUCES 5 MINUTE TEST FOR PROSTATE CANCER SCREENING
Biomerica and Bentley Pharmaceuticals Reach Marketing and Distribution Agreement
Biomerica Receives U.S. FDA Clearance To Market Its New Thyroid Disease Test.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters